108 related articles for article (PubMed ID: 35902957)
1. A unique Levey-Jennings control chart used for internal quality control in human papillomavirus detection.
Peng P; Peng X; Jiao X; Chen N
Virol J; 2022 Jul; 19(1):125. PubMed ID: 35902957
[TBL] [Abstract][Full Text] [Related]
2. A novel use for Levey-Jennings charts in prenatal molecular diagnosis.
Weng B; Xu YL; Ying J; Yang HK; Su L; Yang YM; Chen M
BMC Med Genomics; 2020 Jul; 13(1):109. PubMed ID: 32736662
[TBL] [Abstract][Full Text] [Related]
3. Modified Levey-Jennings charts for calculated laboratory tests.
Coskun A
Clin Chem Lab Med; 2006; 44(4):387-90. PubMed ID: 16599829
[TBL] [Abstract][Full Text] [Related]
4. [Selecting methods of controls concentration for internal quality control and continuity of control chart between different reagent lots for HBsAg qualitative detection].
Li JM; Zheng HJ; Wang LN; Deng W
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):228-31. PubMed ID: 12716523
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of Internal Quality Control Method for Mixed and Split Samples by NAT in Blood Donor Screening].
Tang XY; Ji YP; Feng CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):921-4. PubMed ID: 27342534
[TBL] [Abstract][Full Text] [Related]
6. Implementation of internal quality control program for monitoring of enzyme-linked immunosorbent assay performance at a blood center.
Dubey A; Sonker A
Asian J Transfus Sci; 2021; 15(1):21-29. PubMed ID: 34349453
[TBL] [Abstract][Full Text] [Related]
7. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
9. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E6E7 mRNA and TERC lncRNA in situ detection in cervical scraped cells and cervical disease progression assessment.
Zhao H; He Y; Fan B; Wang Y; Wu YM
Virol J; 2022 Jan; 19(1):18. PubMed ID: 35073959
[TBL] [Abstract][Full Text] [Related]
11. The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
Eklund C; Mühr LSA; Lagheden C; Forslund O; Robertsson KD; Dillner J
J Clin Virol; 2021 Aug; 141():104902. PubMed ID: 34186414
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis.
Cho HW; Shim SR; Lee JK; Hong JH
J Gynecol Oncol; 2022 Jan; 33(1):e4. PubMed ID: 34783207
[TBL] [Abstract][Full Text] [Related]
13. Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques.
de Sanjosé S; Bosch XF; Muñoz N; Chichareon S; Ngelangel C; Balagueró L; Jacobs MV; Meijer CJ; Walboomers JM
Diagn Mol Pathol; 1999 Mar; 8(1):26-31. PubMed ID: 10408790
[TBL] [Abstract][Full Text] [Related]
14. Detection and typing of human papillomavirus nucleic acids in biological fluids.
Coutlée F; Mayrand MH; Roger M; Franco EL
Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.
Gillio-Tos A; De Marco L; Carozzi FM; Del Mistro A; Girlando S; Burroni E; Frayle-Salamanca H; Giorgi Rossi P; Pierotti P; Ronco G;
J Clin Microbiol; 2013 Sep; 51(9):2901-7. PubMed ID: 23804385
[TBL] [Abstract][Full Text] [Related]
16. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
17. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
19. Identification of Multiple High-Risk Human Papillomavirus Infections in a Rural Population of Canatlan, Durango, Mexico.
Favela-Bueno J; Pérez-Morales R; Ramirez-Torres J; Hernandez-Arteaga L; Anguiano-Vega GA
Genet Test Mol Biomarkers; 2020 Jun; 24(6):370-374. PubMed ID: 32429752
[No Abstract] [Full Text] [Related]
20. Cervical cancer prevention: Human papillomavirus testing as primary screening.
Desai S; Zhu MJ; Lapidos-Salaiz I
Cancer; 2022 Mar; 128(5):939-943. PubMed ID: 34767263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
